Pirepemat: IRLAB has Activated all 38 Study Sites in the Phase IIb Study of Pirepemat Aiming to Improve Balance and Reduce Falls

[nednedned]

finance.yahoo.com/news/irla...

irlab.se/project-portfolio/...

Pirepemat (IRL752) is being developed to improve balance and reduce falls, and thus injuries from falls, in people living with Parkinson’s. Falls are a significant consequence of Parkinson’s that has severe complications, such as fractures, impaired mobility and reduced quality of life. Impaired balance and falls are linked to cognitive decline and the progression of Parkinson’s disease.

[Boscoejean]

Pirepemat (IRL752) is a corticalpreferring catecholamine- and cognition-promoting agent. Pirepemat (IRL752) is used for the study of Parkinson's disease.

medchemexpress.com/pirepema....

Clinical trials being conducted in Europe

clinicaltrials.gov/ct2/show...

[Thal]

I use a weighted shoulder wrap.